metamucil and tirzepatide vs. Semaglutide: Which Weight Loss Medication Is Right for You? Switch to Tirzepatide in T2D

It doesnt prescribe or supply medication

The underlying mechanism of how GSH modulate the complex crosstalk between ferroptosis and autophagy remains unclear

Adjusting Background Therapy when Initiating GLP-1 Receptor Agonists: What Pharmacists Need to Know (Module #2) Learning Objective: Explain strategies for managing background therapies when starting a GLP-1 RA in a patient with type 2 diabetes to improve glycemia and/or mitigate cardiovascular and kidney risk

Your clinician will review your progress regularly and help decide how long treatment should continue

Presented for research literature review only Foley V et al